Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
01 07 2021
Historique:
aheadofprint: 30 12 2020
received: 03 07 2020
entrez: 30 12 2020
pubmed: 31 12 2020
medline: 28 5 2021
Statut: epublish

Résumé

Not available.

Identifiants

pubmed: 33375771
doi: 10.3324/haematol.2020.265611
pmc: PMC8252923
doi:

Substances chimiques

Immunologic Factors 0

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

2013-2017

Références

Cell. 2011 Nov 23;147(5):1024-39
pubmed: 22118460
Blood. 2008 Mar 1;111(5):2516-20
pubmed: 17975015
Science. 2014 Jan 17;343(6168):301-5
pubmed: 24292625
Blood. 2011 Nov 3;118(18):4771-9
pubmed: 21860026
Science. 2014 Jan 17;343(6168):305-9
pubmed: 24292623
Cancer Res. 2007 Sep 15;67(18):8839-46
pubmed: 17875725
Cell Rep. 2016 May 17;15(7):1554-1565
pubmed: 27160905
Elife. 2018 Jun 18;7:
pubmed: 29911972
Crit Rev Biochem Mol Biol. 2013 Nov-Dec;48(6):575-608
pubmed: 24088064
Cancer Cell. 2014 Jan 13;25(1):9-11
pubmed: 24434206
J Clin Pharmacol. 2011 May;51(5):731-8
pubmed: 20484616
PLoS One. 2017 Jan 3;12(1):e0169338
pubmed: 28046085
Annu Rev Biochem. 2013;82:139-70
pubmed: 23495937
Leukemia. 2019 Jan;33(1):171-180
pubmed: 30026574
Blood. 2018 Sep 20;132(12):1293-1303
pubmed: 30042095

Auteurs

Matteo Costacurta (M)

Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, The University of Melbourne.

Stephin J Vervoort (SJ)

Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, The University of Melbourne.

Simon J Hogg (SJ)

Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, The University of Melbourne.

Benjamin P Martin (BP)

Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, The University of Melbourne.

Ricky W Johnstone (RW)

Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, The University of Melbourne. ricky.johnstone@petermac.org.

Jake Shortt (J)

Translational Haematology Program, Peter MacCallum Cancer Centre, Melbourne; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville; Monash Haematology, Monash Health, Clayton; Blood Cancer Therapeutics Laboratory, School of Clinical Sciences at Monash Health, Monash University, Clayton. jake.shortt@monash.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH